SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,802.55 |
| Enterprise Value ($M) | 3,038.23 |
| Book Value ($M) | 173.71 |
| Book Value / Share | 1.40 |
| Price / Book | 16.13 |
| NCAV ($M) | -214.67 |
| NCAV / Share | -1.73 |
| Price / NCAV | -13.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.73 |
| Current Ratio | 3.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 237.90 |
| Assets | 626.29 |
| Liabilities | 452.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 240.74 |
| Operating Income | -205.00 |
| Net Income | -205.28 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -153.89 |
| Cash from Investing | -96.16 |
| Cash from Financing | 253.05 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 10.01 | 16.23 | |
| 13G/A | State Street Corp | 6.35 | 14.32 | |
| 13G/A | BlackRock Inc. | 12.40 | 4.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 124,525 | 776,660 | 16.03 | |
| 114,859 | 327,721 | 35.05 | |
| 133,769 | 366,695 | 36.48 | |
| 67,304 | 279,590 | 24.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLS – Apellis Pharmaceuticals, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
| ARVN – Arvinas, Inc. | ASMB – Assembly Biosciences, Inc. |
| ATHA – Athira Pharma, Inc. |